(Q43605237)

25 November 2017

The effects of bisoprolol, a selective beta1-blocker, on glucose metabolism by long-term administration in essential hypertension (English)

1 reference

25 November 2017

0 references

1 reference

Owada A

1

1 reference

25 November 2017

Suda S

series ordinal

2

1 reference

25 November 2017

Hata T

series ordinal

3

1 reference

25 November 2017

Miyake S

series ordinal

4

1 reference

25 November 2017

1 May 2001

1 reference

Clinical and Experimental Hypertension

25 November 2017

1 reference

25 November 2017

23

1 reference

25 November 2017

4

1 reference

25 November 2017

305-316

1 reference

USE OF PROPRANOLOL (INDERAL) IN TREATMENT OF HYPERTENSION.

25 November 2017

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100102669

Management of raised blood pressure in New Zealand: a discussion document

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100102669

Effect of beta-blocking drugs on beta-cell function and insulin sensitivity in hypertensive non-diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100102669

Characterization of [3H](+/-)carazolol binding to beta-adrenergic receptors. Application to study of beta-adrenergic receptor subtypes in canine ventricular myocardium and lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100102669

Beta-adrenoceptor antagonists (non-selective as well as beta 1-selective) with partial agonistic activity decrease beta 2-adrenoceptor density in human lymphocytes. Evidence for a beta 2-agonistic component of the partial agonistic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100102669

Effects of angiotensin-converting enzyme inhibitors, Ca2+ channel antagonists, and alpha-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100102669

Antihypertensive therapy with enalapril improves glucose storage and insulin sensitivity in hypertensive patients with non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100102669

The cardioselectivity of beta adrenoceptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100102669

Influence of Beta-Blocking Drugs on Glucose Metabolism in Hypertensive, Non-Diabetic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100102669

Insulin resistance in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100102669

Influence of heart rate on mortality among persons with hypertension: the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCEH-100102669

21 January 2018

Identifiers

DOI

10.1081/CEH-100102669

1 reference

25 November 2017

1 reference